Antibody titers after a third dose of the SARS-CoV-2 BNT162b2 vaccine in immunocompromised adults in Greece: Is a fourth dose necessary?
Date
2022Language
en
Sujet
Résumé
Real-world data suggest that protection against COVID-19 declines a few months after vaccination, particularly in the elderly and immunocompromised individuals. Our study aimed to analyze the humoral response induced by a third supplemental dose of BNT162b2 vaccine in a mixed group of immunocompromised individuals by determining anti-spike (anti-S) IgG antibody titers at baseline (pre-third vaccine dose) and 4 weeks after the dose. Serum samples were obtained from a total group of 85 immunocompromised individuals (history of cancer: n = 20, lymphoma: n = 4, leukemia: n = 3, transplant recipients: n = 4, autoimmune disease: n = 42, inflammatory disease: n = 6, autoimmune diabetes type 1: n = 6) all of whom had previously received a two-dose schedule of the vaccine. The average number of days between second and third dose was 139.6145 (±41.39071). The overall IgG GMCs 4 weeks postvaccination were increased by more than 35 times (fold change = 35.30, p < 0.001). Fold changes were not significantly correlated with underlying condition, age, sex nor with days between second and third dose. Considering the predominance of omicron variants in the current period and the results of studies showing a decrease in the effectiveness of the third dose after 10 weeks we highly recommend a fourth dose to this vulnerable population group. © 2022 Wiley Periodicals LLC.
Collections
Related items
Showing items related by title, author, creator and subject.
-
Efficacy of an AS03 A-adjuvanted split H5N1 influenza vaccine against an antigenically distinct low pathogenic H5N1 virus in pigs
De Vleeschauwer, A. R.; Baras, B.; Kyriakis, C. S.; Jacob, V.; Planty, C.; Giannini, S. L.; Mossman, S.; Van Reeth, K. (2012)We used the pig model of influenza to examine the efficacy of an AS03 A-adjuvanted split H5N1 (A/Indonesia/05/2005) vaccine against challenge with a low pathogenic (LP) H5N1 avian influenza (AI) virus (duck/Minnesota/1525/1981) ... -
Defining antibody seroprevalence and duration of humoral responses to sars-cov-2 infection and/or vaccination in a greek community
Kotsiou O.S., Papagiannis D., Fradelos E.C., Siachpazidou D.I., Perlepe G., Miziou A., Kyritsis A., Vavougios G.D., Kalantzis G., Gourgoulianis K.I. (2022)Background: In this work we aimed to evaluate antibody-response longevity to SARS-CoV-2 infection and/or vaccination in one of the Greek communities that was worst hit by the pandemic, Deskati, five months after a previous ... -
Factors influencing the outcome of primary immunization against rabies in young dogs
Tasioudi K.E., Papatheodorou D., Iliadou P., Kostoulas P., Gianniou M., Chondrokouki E., Mangana-Vougiouka O., Mylonakis M.E. (2018)There is currently limited information on the factors influencing the outcome of rabies vaccination in dogs based on the primary immunization schedule. The objective of this study was to investigate whether selected variables ...